Gustavo
@gusviani
Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo (USP).
ID:77641454
27-09-2009 02:47:47
979 Tweets
1,2K Followers
512 Following
Follow People
Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low- and Middle-Income Settings mdpi.com/2654488 #mdpicancers via Cancers MDPI Dr. Fabio Moraes Gustavo @andregouv Andre G, MD, Rad Onc 🇧🇷 🇮🇹 🇨🇦
🎙 dose-escalation RT efforts for 👥 with #Colorectal liver metastases❗️OncoAlert Memorial Sloan Kettering Radiation Oncology
📌RETRO STUDY
Patients:90 w/ 122 treated lesions (2006-2019)
Treatment:Various RT schemes, median dose 97.9 Gy
📊RESULTS
➖Median FU:26.4 m
➖Local control (FFLP) at 2 y:42%
➖OS at 2…
🎙SBRT produces excellent local control and ⬇️⬇️ complications for non-spine bone metastases(NSBM)❗️OncoAlert Dr. Fabio Moraes Andre G, MD, Rad Onc 🇧🇷 🇮🇹 🇨🇦 IJROBP - The Red Journal
🥇🎯efficacy and safety of SBRT for NSBM
📌SR/MA of 7 studies (807 👥/1048 llesions)
📊RESULTs
- 1-y LF and fracture rates…
🎙️ Primary 🔪 was an 👎 strategy, compared to preop CRT ➡️🔪, and cannot be recommended for #rectalcancer 👥 in the clinical practice‼️OncoAlert IJROBP - The Red Journal
📌RCT on LARC 👥 (6–12 cm) w/ (-) MRI-predicted MRF. Randomized into intervention (primary 🔪 w/ selective CRT) or control…
🎙️SBRT is a viable alternative for medically inoperable or high-risk #renalcancer ‼️OncoAlert The Lancet Oncology
📌SR, based on 36 studies (822 👥)
📊Results
- Median LC rate: 94.1%
- 5-y PFS: 80.5%
5-y OS: 77.2%
- Practice guidelines recommend 25–26 Gy in 1 fr or 42–48 Gy in 3…
Dear Colleagues,
Out Tomorrow, The OncoAlert 🚨Newsletter
REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…
Discussing🎄
✅SPLASH in #ProstateCancer 💦
✅Top Advances in #OvarianCancer 🦀
✅Risk for early #PancreaticCancer
✅Precision Medicine in Urothelial…
Actions are needed to promote Radiation therapy capacity expansion in Brazil - Dr. Fabio Moraes
Timothy Hanna
#Brazil #Brazil ianRadiotherapy #RadiationOncology #Oncology #Cancer #OncoDaily #RadiationTherapy #Cancer Care
oncodaily.com/26458.html
The Brazilian RT expansion plan showed substantial delays in most projects.
Significant delays were observed in the basic and construction projects phases.
Actions are needed to promote RT capacity expansion in Brazil.
Queen’s Global Oncology Program Gustavo Andre G, MD, Rad Onc 🇧🇷 🇮🇹 🇨🇦 Dr. Gustavo Nader Marta, MD, PhD
Truly OUTSTANDING work by MD Anderson Cancer Center Jillian Gunther on her Ph2 trial of response adapted ultra low dose (4Gy) RT for gastric MALT. 24 pts,4 required the additional 20 Gy.All pts had a CR to the response adapted program, 3yr LC 96% & 3yr freedom from distant relapse 96% #ASH2023
🎙️Avasopasem w/ SBRT showed efficacy in advanced #pancreatic cancer ‼️@oncoalert The Lancet Oncology
📌Ph 1b/2 trial, randomized, double-blind, placebo-controlled
- 👥 (n=42) received avasopasem or placebo before SBRT
🥇🎯: Evaluate avasopase w/SBRT
📊RESULTs
- Avasopasem…
In order to present suggestions to improve the Radiotherapy Expansion Program in the Unified Health System (PER-SUS) we conducted a detailed study available at the link below.
sciencedirect.com/science/articl…
Thanks to all the authors! Dr. Fabio Moraes Gustavo Dr. Gustavo Nader Marta, MD, PhD